Recent advances in precision medicine for pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer mortality worldwide. Although advances in systemic chemotherapy for PDAC have improved survival outcomes for patients with the disease, chemoresistance is a major treatment issue for unselected PDAC patient populations. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayashi, Hiromitsu, Higashi, Takaaki, Miyata, Tatsunori, Yamashita, Yo‐ichi, Baba, Hideo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316748/
https://www.ncbi.nlm.nih.gov/pubmed/34337294
http://dx.doi.org/10.1002/ags3.12436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316748/
https://www.ncbi.nlm.nih.gov/pubmed/34337294
http://dx.doi.org/10.1002/ags3.12436

Ejemplares similares